Prevalência de dor neuropática em pacientes com osteoartrite

María Eugenia Zuluaga; Iveth Urbano; María Ana Tovar-Sanchez; Catalina Baena; Sara G. Pacichana-Quinayaz; Francisco J. Bonilla-Escobar

doi:10.1055/s-0043-1776986

Revista Brasileira de Ortopedia, Table of Contents

CC BY-NC-ND 4.0 · Rev Bras Ortop (Sao Paulo) 2023; 58(06): e924-e931
DOI: 10.1055/s-0043-1776986

Artigo Original

Joelho/Quadril

Prevalence of Neuropathic Pain in Patients with Osteoarthritis

Article in several languages: português | English

María Eugenia Zuluaga

¹Especialista em Medicina Física e Reabilitação, Universidad del Valle, Cali, Colômbia

²Grupo de Investigação em Reabilitação, Universidad del Valle, GIRUV, Universidad del Valle, Cali, Colômbia

,

Iveth Urbano

¹Especialista em Medicina Física e Reabilitação, Universidad del Valle, Cali, Colômbia

²Grupo de Investigação em Reabilitação, Universidad del Valle, GIRUV, Universidad del Valle, Cali, Colômbia

,

María Ana Tovar-Sanchez

¹Especialista em Medicina Física e Reabilitação, Universidad del Valle, Cali, Colômbia

²Grupo de Investigação em Reabilitação, Universidad del Valle, GIRUV, Universidad del Valle, Cali, Colômbia

,

Catalina Baena

¹Especialista em Medicina Física e Reabilitação, Universidad del Valle, Cali, Colômbia

²Grupo de Investigação em Reabilitação, Universidad del Valle, GIRUV, Universidad del Valle, Cali, Colômbia

,

Sara G. Pacichana-Quinayaz

³Fundacíon SCISCO, Somos Ciencia al Servicio de la Comunidad, Cali, Colômbia

,

Francisco J. Bonilla-Escobar

³Fundacíon SCISCO, Somos Ciencia al Servicio de la Comunidad, Cali, Colômbia

⁴Departamento de Oftalmologia, Institute for Clinical Research Education (ICRE), School of Medicine, University of Pittsburgh, Pensilvânia, Estados Unidos.

⁵Service of Ophthalmology, Universidad del Valle, Cali, Colômbia

› Author Affiliations

Abstract

Objective The aim of this study was to determine the prevalence of neuropathic pain and characterize the quality of life of patients with osteoarthritis who consulted a pain clinic in Southwestern Colombia.

Methods A cross-sectional study was conducted via telephone survey. Participants ≥18 years of age with a diagnosis of osteoarthritis were included. The LANSS questionnaire was used to evaluate symptoms and signs of neuropathic pain, and the Short Form-8 was used to evaluate quality of life.

Results Response rate was 54.1% (46/85). The male-to-female ratio was 5:1, with an average age of 72 ± 10 years. Most participants (91.3%) had severe pain. The prevalence of neuropathic pain was 28.3% (95%CI = 15.99-43.46), and the prevalence of neuropathic pain amongst women was 84.6% (95%CI = 54.55-98.01). Dysesthesias and paroxysmal pain were present in 92.3% of individuals with neuropathic pain. Regarding quality of life, limitations in physical activity were the most significant, as 63% of individuals reported such limitations.

Conclusion Neuropathic pain was found to be prevalent and had a negative impact on physical function, highlighting the need for therapeutic strategies targeted to specific neuropathic pain pathways in patients with osteoarthritis.

Keywords

chronic pain - neuralgia - quality of life - osteoarthritis

Full Text

References

Referências
1 Sen R, Hurley JA. Osteoarthritis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020
2 Lane NE, Shidara K, Wise BL. Osteoarthritis year in review 2016: clinical. Osteoarthritis Cartilage 2017; 25 (02) 209-215
3 Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol 2014; 10 (07) 437-441
4 Kolasinski SL, Neogi T, Hochberg MC. , et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis care & research (2010). 2020; 72 (02) 149-162
5 Hochberg MC, Altman RD, April KT. et al; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012; 64 (04) 465-474
6 Sakuta M. [One hundred books which built up neurology (37)-Charcot JM “Leçons sur les Localsations das les Maladies du Cerveau et de la Moelle Epinière faites a la Faculté de Médecine de Paris”(1876-1880)]. Brain Nerve 2010; 62 (01) 90-91
7 McDougall JJ, Linton P. Neurophysiology of arthritis pain. Curr Pain Headache Rep 2012; 16 (06) 485-491
8 French HP, Smart KM, Doyle F. Prevalence of neuropathic pain in knee or hip osteoarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2017; 47 (01) 1-8
9 Pain IAftSo. IASP Terminology. IASP Press. https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698#Neuropathicpain . Published 1994 . Updated 14/12/17. [Accessed 05/01, 2021] .
10 Thakur M, Dickenson AH, Baron R. Osteoarthritis pain: nociceptive or neuropathic?. Nat Rev Rheumatol 2014; 10 (06) 374-380
11 van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 2014; 155 (04) 654-662
12 Colloca L, Ludman T, Bouhassira D. et al. Neuropathic pain. Nat Rev Dis Primers 2017; 3: 17002
13 Weingarten TN, Watson JC, Hooten WM. et al. Validation of the S-LANSS in the community setting. Pain 2007; 132 (1-2): 189-194
14 López-de-Uralde-Villanueva I, Gil-Martínez A, Candelas-Fernández P, de Andrés-Ares J, Beltrán-Alacreu H, La Touche R. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale. Neurologia (Engl Ed) 2018; 33 (08) 505-514 (Engl Ed)
15 Vallès J, Guilera M, Briones Z, Gomar C, Canet J, Alonso J. ARISCAT Group. Validity of the Spanish 8-item short-form generic health-related quality-of-life questionnaire in surgical patients: a population-based study. Anesthesiology 2010; 112 (05) 1164-1174
16 Clasificación estadística internacional de enfermedades y problemas relacionados con la salud: décima revisión (CIE-10), volúmenes 1, 2 y 3 en CD-Rom. Rev Esp Salud Pública 2004; 78: 647-648
17 Finnerup NB, Attal N, Haroutounian S. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14 (02) 162-173
18 Hochman JR, Davis AM, Elkayam J, Gagliese L, Hawker GA. Neuropathic pain symptoms on the modified painDETECT correlate with signs of central sensitization in knee osteoarthritis. Osteoarthritis Cartilage 2013; 21 (09) 1236-1242
19 Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 2004; 42 (01) 1-9 , v
20 Wluka AE, Cicuttini FM, Spector TD. Menopause, oestrogens and arthritis. Maturitas 2000; 35 (03) 183-199
21 Prieto-Alhambra D, Judge A, Javaid MK, Cooper C, Diez-Perez A, Arden NK. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis 2014; 73 (09) 1659-1664
22 Reginato AM, Riera H, Vera M. et al; Pan-American League of Associations for Rheumatology (PANLAR) Osteoarthritis Study Group. Osteoarthritis in Latin America: Study of Demographic and Clinical Characteristics in 3040 Patients. J Clin Rheumatol 2015; 21 (08) 391-397
23 Charles ST, Carstensen LL. Social and emotional aging. Annu Rev Psychol 2010; 61: 383-409
24 Beard JR, Officer A, de Carvalho IA. et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet 2016; 387 (10033): 2145-2154
25 Schaible HG. Osteoarthritis pain. Recent advances and controversies. Curr Opin Support Palliat Care 2018; 12 (02) 148-153
26 McDougall JJ, Albacete S, Schuelert N. et al. Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain. Osteoarthritis Cartilage 2017; 25 (06) 926-934
27 Dimitroulas T, Duarte RV, Behura A, Kitas GD, Raphael JH. Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment. Semin Arthritis Rheum 2014; 44 (02) 145-154
28 Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother 2009; 9 (05) 745-758